A Prediction Model of Prolonged Mechanical Ventilation Following Acute Type A Aortic Dissection Surgery
Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Apr 8, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing a tool to predict which patients may need to stay on a breathing machine (mechanical ventilation) for a longer time after surgery for acute type A aortic dissection, a serious heart condition. The study aims to understand how often this happens, how long patients might need to stay in the intensive care unit (ICU), and the overall risks involved after surgery.
To participate, individuals must be at least 18 years old and have been diagnosed with acute type A aortic dissection through specific imaging tests. They should also have undergone surgery that required the use of a heart-lung machine and have been placed on a breathing machine in the ICU. However, those with certain severe health issues or who unfortunately do not survive the first few days after surgery will not be included in this study. While the trial is not yet recruiting participants, it aims to gather important information that could help improve outcomes for future patients undergoing similar surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years;
- • Diagnosis of acute type A aortic dissection (ATAAD) confirmed by computed tomography angiography and echocardiography;
- • Patients who underwent aortic surgery requiring cardiopulmonary bypass (CPB), were admitted to the surgical intensive care unit (SICU), and received mechanical ventilation.
- Exclusion Criteria:
- • Reintubation;
- • Intraoperative death or failure to survive beyond 72 hours postoperatively;
- • Pregnancy;
- • Severe comorbidities (e.g., lung cancer);
- • Missing critical outcome data (e.g., short-term mortality, mechanical ventilation duration, reintubation).
About China Japan Friendship Hospital
China-Japan Friendship Hospital is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. Established as a collaborative effort between China and Japan, the hospital integrates cutting-edge technology with traditional medical practices, fostering a multidisciplinary approach to patient care and clinical studies. The institution is committed to enhancing therapeutic outcomes and improving patient safety while adhering to rigorous ethical standards. With a diverse team of experienced healthcare professionals and researchers, China-Japan Friendship Hospital plays a pivotal role in addressing global health challenges and contributing to medical knowledge through its extensive clinical trial programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported